Boston Scientific CFO acquires shares via 401(k) plan

Boston Scientific EVP and CFO Jonathan Monson reported an indirect acquisition of 9,908 shares of Boston Scientific common stock on 2026-08-10 at $50.46 per share.

Rhea-AI Filing Summary

Boston Scientific EVP and CFO Jonathan Monson reported an indirect acquisition of 9,908 shares of Boston Scientific common stock on 2026-08-10 at $50.46 per share. The footnote states this was a discretionary rebalancing election under the company’s 401(k) Retirement Savings Plan, treated as a discretionary transaction under Rule 16b-3(f). After this transaction, he indirectly holds 9,908 shares through the 401(k) and separately reports 39,063 shares held directly.

Insider Trade Summary

Discretionary: 9,908 shares

Discretionary 2 txns

Insider Monson Jonathan

Role EVP and CFO

Type	Security	Shares	Price	Value
Discretionary	Common Stock F1	9,908	$50.46	$500K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 9,908 shares (Indirect, By 401(k)); Common Stock — 39,063 shares (Direct)

Footnotes (1)

1. F1. Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.

Key Figures

Indirect shares acquired: 9,908 shares Transaction price: $50.46 per share Indirect holdings after transaction: 9,908 shares +1 more

4 metrics

Indirect shares acquired 9,908 shares Discretionary 401(k) rebalancing transaction on 2026-08-10

Transaction price $50.46 per share Price for 9,908 indirectly acquired common shares

Indirect holdings after transaction 9,908 shares Indirect ownership via company 401(k) plan

Direct holdings reported 39,063 shares Directly owned Boston Scientific common stock after reported activity

Key Terms

Rule 16b-3(f), 401(k) Retirement Savings Plan, discretionary transaction, indirect ownership

4 terms

Rule 16b-3(f) regulatory

"resulted in a discretionary transaction in shares of the Company's common stock."

401(k) Retirement Savings Plan financial

"under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction"

discretionary transaction financial

"which resulted in a discretionary transaction in shares of the Company's common stock."

indirect ownership financial

"indirectly holds 9,908 shares through the 401(k)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Boston Scientific (BSX) EVP and CFO Jonathan Monson report in this Form 4?

Jonathan Monson reported an indirect acquisition of 9,908 BSX shares of common stock at $50.46 per share, resulting from a discretionary rebalancing election under the company’s 401(k) Retirement Savings Plan on 2026-08-10.

How many Boston Scientific (BSX) shares does Jonathan Monson hold after this transaction?

Following the reported activity, Jonathan Monson holds 9,908 BSX shares indirectly via the company’s 401(k) plan and separately reports 39,063 BSX shares directly, according to the post-transaction ownership figures in the filing.

Was the Boston Scientific (BSX) Form 4 transaction by Jonathan Monson a market purchase?

The Form 4 describes the event as a discretionary transaction under Rule 16b-3(f) tied to a 401(k) plan rebalancing election, rather than a standard open-market purchase, even though it reflects an acquisition of 9,908 common shares.

At what price were Jonathan Monson’s new Boston Scientific (BSX) shares acquired?

The 9,908 indirectly held BSX shares associated with the 401(k) rebalancing transaction were reported at a price of $50.46 per share, as shown in the non-derivative transaction details for 2026-08-10.

How is the 401(k) ownership of Boston Scientific (BSX) shares characterized for Jonathan Monson?

The 9,908 BSX shares are reported as indirectly owned “By 401(k)”, reflecting holdings in the company’s 401(k) Retirement Savings Plan rather than direct personal brokerage ownership, with the transaction noted as discretionary under Rule 16b-3(f).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/11/2026 - 04:40 PM Accepted by SEC EDGAR 08/11/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Monson Jonathan

(Last) (First) (Middle)

300 BOSTON SCIENTIFIC WAY

(Street)

MARLBOROUGH MASSACHUSETTS 01752-1234

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/10/2026		I(1)		9,908	A	$50.46	9,908	I	By 401(k)
Common Stock								39,063	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquistion made pursuant to an election by the reporting person to rebalance their holdings under the Company's 401(k) Retirement Savings Plan, which resulted in a discretionary transaction in shares of the Company's common stock.

	/s/ Susan Thompson, Attorney-in-Fact	08/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)